Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06701032

Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program

The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program).

Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Peripheral Artery Disease (PAD) Angina Pectoris Arterial Occlusive Diseases Arteriosclerosis Atherosclerosis Cardiovascular Diseases Cerebrovascular Atherosclerosis Chest Pain Coronary Artery Disease Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) Coronary Disease Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Peripheral Arterial Disease Peripheral Vascular Diseases Signs and Symptoms Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CLSC de Lévis - Programme PREV du CISSS de Chaudière-Appalaches

Lévis, Quebec, G6V 0M4, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any individual aged 18 years and older who has been diagnosed with peripheral artery disease, coronary artery disease, angina, ischemic heart failure, transient ischemic attack or ischemic stroke (non-cardioembolic, non-hemorrhagic);
  • Have been admitted to the PREV program;

Exclusion criteria

  • Being not able to give written informed consent;

Treatment and study plan

Cardiovascular rehabilitation program

Other

The cardiovascular rehabilitation program consists of a 12 weeks supervised exercises therapy (either in person or in tele-care)

Primary outcomes

  1. Change in toe pressure measurement

    Time frame: Change from baseline to 12 weeks

    Results will be measured in mm Hg

  2. Change in the toe-brachial index

    Time frame: Change from baseline to 12 weeks

  3. Change in the ankle-brachial index

    Time frame: Change from baseline to 12 weeks

Secondary outcomes

  1. Change in 6-minute walk test (6MWT)

    Time frame: Change from Baseline to 12 weeks

    Results will be measured in meters

  2. Short Form Health Survey 36 (SF-36)

    Time frame: Change from baseline to 12 weeks

    Change in quality of life measured using the SF-36 questionnaire. The scores range from 0-100.

Sponsors and collaborators

Lead sponsor

Laval University

Other

Collaborators

  • CISSS de Chaudière-Appalaches

Registry information

Official study title

Evolution of Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation (PREV) Program: a Prospective Cohort Study.

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Nov 22, 2024
Registry last updated
Jun 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.